Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Longitudinal, Observational Study in Newly Diagnosed Multiple Myeloma (MM) Patients to Assess the Relationship Between Patient Outcomes, Treatment Regimens and Molecular Profiles

NCT01454297 is registered in ClinicalTrials.gov with Multiple Myeloma Research Foundation as lead sponsor.

NCT NCT01454297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01454297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Longitudinal, Observational Study in Newly Diagnosed Multiple Myeloma (MM) Patients to Assess the Relationship Between Patient Outcomes, Treatment Regimens and Molecular Profiles
Lead sponsor
Multiple Myeloma Research Foundation
Phase
Observational
Overall status
Completed
Start date
July 31, 2011
Completion date
December 31, 2023
Enrollment
1,154 (actual)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma